HARVARD BIOSCIENCE INC
No enriched coverage for $HBIO in the last 7 days.
No SEC Form 4 filings for $HBIO in the last 30 days.
The article reports on the discontinued operations of Harvard Bioscience, Inc., traded on the Frankfurt Stock Exchange under the symbol HBI0. It appears to be a financial news brief, likely indicating a change in the company's operational status. The content is brief and serves as a notification regarding this financial event.
HOLLISTON, Mass., Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- Harvard Bioscience, Inc. HBIO ( the "Company" or "Harvard Bioscience" ) today announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. Mr. DeNelsky will also serve on the Board's Nominating and ...
HOLLISTON, Mass., June 02, 2025 ( GLOBE NEWSWIRE ) -- Harvard Bioscience, Inc. HBIO ( the "Company" ) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees.
